PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Phenotype | |diabetes |
| Sentences | 145 |
| PubMedID- 24072996 | In the latest nhanes survey [1], the estimated 10-year ukpds risk for developing coronary heart disease among people with diabetes was 22% lower in the 2007-2008 survey compared to the 1999-2000 surveys. |
| PubMedID- 23496967 | Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: lp(a) phenotype, lymphocyte, and coronary heart disease. |
| PubMedID- 22910888 | Also, high plasma adiponectin levels are associated with a lower risk of myocardial infarction in men [107], a reduced coronary heart disease risk in patients with diabetes mellitus [108], and a lower risk of acute coronary syndrome [109] (figure 1). |
| PubMedID- 23653531 | Patients having systemic hypertension, diabetes mellitus, history of ischemic heart disease, significant valvular heart disease, chronic obstructive pulmonary disease, hypo- or hyperthyroidism, renal failure or any associated systemic disease were excluded. |
| PubMedID- 20040882 | Purpose: the cardiovascular disease risk profile and exercise capacity of coronary heart disease patients with type 2 diabetes mellitus (dm) were measured and compared with those of nondiabetic (ndm) patients before and after a 6-week multidisciplinary cardiac rehabilitation program. |
| PubMedID- 26190179 | Background: type 2 diabetes (dmt2) combined with ischemic heart disease (ihd) promotes the occurrence and development of coronary atherosclerosis. |
| PubMedID- 25324535 | The table shows how age, sbp, cholesterol, smoking (where ‘smoker’ is defined as somebody smoking 20 cpd) and simd influence life expectancy while holding diabetes and family history of heart disease constant at their average values. |
| PubMedID- 24002369 | Adjusted for age, sex, systolic blood pressure, heart rate, electrocardiographic left ventricular hypertrophy, clinically significant murmur, body mass index, diabetes mellitus, and history of coronary heart disease. |
| PubMedID- 22021872 | Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study. |
| PubMedID- 24559091 | Universal programs focusing on comorbid heart disease among patients with diabetes may be important. |
| PubMedID- 20922871 | [hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus]. |
| PubMedID- 22260235 | It has been shown to be a powerful independent marker of coronary heart disease events in patients with diabetes [6]. |
| PubMedID- 24620001 | The change in basic food structure is operating to distort biology even before conception and into late years, with the epidemic of obesity and diabetes likely to lead to stroke, heart disease, and now dementia, being flagged as a consequence. |
| PubMedID- 25666934 | Recent study has revealed negative correlations between levels of srage and coronary heart disease in diabetes [26]. |
| PubMedID- 25633574 | Associations between plasma fibulin-1, pulse wave velocity and diabetes in patients with coronary heart disease. |
| PubMedID- 21736547 | Such risk reduction for coronary heart disease events in patients with type 2 diabetes was not observed by improved glycemic control achieved by intensified treatment with insulin and glibenclamid [138]. |
| PubMedID- 23483825 | In patients with acute stroke, there was no significant association between serum uric acid level and diabetes mellitus, hypertension, history of ischemic heart disease, smoking, prescription rtpa, and type of stroke. |
| PubMedID- 24404513 | diabetes increases the risk of coronary heart disease, stroke, and peripheral arterial disease by 2- to 4-fold [2]. |
| PubMedID- 22682035 | Moreover, diabetes increases one’s chances of having heart disease by as much as four to six times, while end stage renal disease, a common consequence of poorly managed diabetes, increases one’s risk of heart disease by twenty times [13]. |
| PubMedID- 23220502 | Methods: a total of 132 type 2 diabetes mellitus without coronary heart disease (t2dm) cases and 135 type 2 diabetes mellitus with coronary heart disease (t2dm+chd) cases received intensive glycemic control. |
| PubMedID- 25454625 | Influence of glucose-lowering rate on ckmb and myoglobin serum levels in type-2 diabetes patients with coronary heart disease. |
| PubMedID- 21773014 | Since the increase in adiposity is related to general poor health factors such as an increase in type ii diabetes and increased incidence of coronary heart disease, exercise to reduce adiposity is recommended for the ageing population. |
| PubMedID- 22783203 | #adjusted for age (70–74, 75–79, 80–84, and 85+ years), sex, body mass index, hypertension, hypercholesterolemia, diabetes, history of coronary heart disease, history of stroke, history of renal disease, history of hepatic disease, drinking status, smoking status, physical activity, physical performance, depressive symptoms, mini-mental state examination, and use of tranquilizers. |
| PubMedID- 22693502 | Type 1 diabetes mellitus, hypertension, history of ischemic heart disease, renal impairment (serum creatinine >150 umol/l), and valvular heart diseases were excluded. |
| PubMedID- 24524426 | Demographic and cvd risk characteristics (eg, age, sex, told by a health professional they had diabetes, family history of heart disease) and the setting of program implementation (ie, clinic, community based organization [cbo], or other type of site) were included in the models as control or predictor variables. |
| PubMedID- 22263120 | However, considering ischemic heart disease directly related with diabetes, diabetes followed by ischemic heart disease acted as a risk factor by affecting primary patency rate (p=0.040). |
| PubMedID- 22954960 | Purpose: diabetes increases the risk of ischemic heart disease (ihd). |
| PubMedID- 21499988 | It is estimated that in the next 10 years, the majority of all heart disease will be associated with type 2 diabetes mellitus [63]. |
| PubMedID- 22465850 | Analyses were stratified by recruitment region (ten regions) and adjusted for: socio-economic status (quintiles using the townsend index [22]), smoking status (current, past, never), alcohol consumption (0, 1–2, 3–6, 7–14, ≥ 15 drinks per week), menopausal hormone therapy use (never, past, current), diabetes (yes, no), history of heart disease/thrombosis (yes, no), history of osteo/rheumatoid arthritis (yes, no), thyroid disease (yes, no), and height (< 155, 155.0 to 159.9, 160 to 164.9, 165.0 to 169.9, or ≥ 170 cm). |
| PubMedID- 21274332 | Also, it has been shown that qtc interval prolongation in adults with type 2 diabetes is associated with ischemic heart disease (11), and that patients with prolonged qtc interval have higher mortality from cardiovascular disease (12). |
| PubMedID- 25539716 | Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24705616 | Given the known clustering of traditional cardiovascular risk factors and coronary heart disease with diabetes, this study sought to investigate the independent association between diabetes and the presence and severity of vascular disease in the peripheral arteries. |
| PubMedID- 23033926 | Data on comorbidities were collected including hypertension, diabetes and history of ischemic heart disease. |
| PubMedID- 23413692 | [increased myelopepoxidase activity is a risk factor for ishemic heart disease in patients with diabetes mellitus]. |
| PubMedID- 23676456 | The diseases comprised coronary heart disease (chd), chd associated with diabetes mellitus (dm), valvular heart disease and congenital heart disease. |
| PubMedID- 22547909 | Individuals with diabetes have increased risk of coronary heart disease compared with nondiabetic individuals, and the risk of cardiovascular deaths is as high as in nondiabetic individuals with previous myocardial infarction [28]. |
| PubMedID- 20523342 | Patients with type 1 diabetes mellitus, a history of ketoacidosis, ischemic heart disease, congestive heart failure or trauma, kidney or liver diseases, patients receiving insulin treatment and pregnant or lactating women were excluded from this study. |
| PubMedID- 24816637 | Description of the general population they have in charge (general population), of diabetic patients (diabetes), of patients with ischaemic heart disease (ihd) and of patients with heart failure (hf). |
| PubMedID- 23780949 | The primary risk factors for heart disease associated with diabetes include dyslipidemia, elevated bmi, poor glycemic control, hypertension, insulin resistance, and history of smoking (8). |
| PubMedID- 21203594 | Background: recent findings indicate that symptomatic heart disease in patients with diabetes mellitus predicts poor prognosis, but cardiac involvement may occur before clinical manifestation. |
| PubMedID- 25999755 | The prevalence of dm in the us has more than doubled over the past decade, and dm is a major risk factor for cardiovascular disease.1 in addition to being at increased risk of developing coronary heart disease, patients with diabetes experience higher hospital mortality rates after acute myocardial infarction (ami) than patients without diabetes.2–5 chronic kidney disease (ckd) is also a relatively common condition in the general population with more than 26 million american adults estimated to have ckd;6,7 this condition is also associated with considerable morbidity and mortality. |
| PubMedID- 20228159 | Aims: information on medicine use among coronary heart disease (chd) patients with diabetes in unselected patient populations is scarce. |
| PubMedID- 22107872 | diabetes is often associated with heart disease and worsens the prognosis of patients with heart conditions. |
| PubMedID- 21357366 | The excess risk for future coronary heart disease (chd) events attributable to diabetes alone in the absence of coexisting chd was not well understood until the publication by haffner et al. |
| PubMedID- 23302697 | Having a history of coronary heart disease with diabetes mellitus exhibited a 2.29-fold increased risk for stroke or tia during the 4.8- to 8.1-year follow-up period than patients without diabetes. |
| PubMedID- 26186740 | Clinical evidence shows that circulating levels of adipocyte fatty-acid-binding protein (a-fabp) are elevated in patients with diabetes and closely associated with ischaemic heart disease. |
| PubMedID- 24373412 | Moreover, the prevalence of coronary heart disease in patients with type 2 diabetes was found to be significantly higher in patients with cca-imt ≥ 1.1 mm than < 1.1 mm[9]. |
| PubMedID- 23172970 | Mortality from ischemic heart disease in individuals with type 1 diabetes is substantial. |
| PubMedID- 25485902 | diabetes mellitus increases morbidity/mortality of ischemic heart disease. |
| PubMedID- 26182732 | Conclusion: serum adiponectin concentration is markedly decreased in patients of type-2 diabetes with coronary heart disease. |